Facebook
Twitter
LinkedIn
ForwardThis series is for clinicians, nurses, APPs to have a forum to discuss the management of complex lymphoma cases. During this we discuss appropriate management options, clinical trial availability, and recently published data that would guide our decision making. We review pathology, radiological images, and clinical course for each patient presented.
Lymphoma, Treatment, Pathology, Leukemia
- Physicians
- Nurse Practitioners
- Physician Assistants
- Nurses
- Pharmacists
- Psychologists
- Social Workers
Participants who engage in this educational intervention will be able to:
- Manage various complex lymphoma cases
- Utilize diagnostic and pathological tools utilized to characterize a lymphoma
- Improve patient outcomes through group discussion
Nirav Shah, MD (Activity Director)
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Sumana Devata, MD
Associate Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Timothy Fenske, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Mehdi Hamadani, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
Walter Longo, MD
Professor Department of Medicine
Division of Hematology & Oncology
The Medical College of Wisconsin
- Sumana Devata, MD
- Walter Longo, MD
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.
| Name | Company | Role |
|---|---|---|
| Nirav Shah, MD | Loxo-Lilly | Consultant, Researcher |
| Miltenyi Biotec | Consultant, Researcher | |
| Epizyme | Advisory Board | |
| Janssen | Advisory Board | |
| Kite Pharma | Advisory Board | |
| Incyte | Advisory Board | |
| Seattle Genetics | Advisory Board | |
| Novartis | Advisory Board | |
| BMS-Juno | Advisory Board | |
| TG Therapeutics | Advisory Board | |
| Umoja | Advisory Board | |
| Tundra Therapeutics | Advisory Board/Founder | |
| Timothy Fenske, MD | AstraZeneca | Consultant/Speaker |
| Kite Pharmaceuticals | Consultant/Speaker | |
| Beigene | Consultant/Speaker | |
| AbbVie | Consultant | |
| Seagen | Consultant/Speaker | |
| Adaptive Biotechnologies | Consultant | |
| TG Therapeutics | Speaker | |
| Lilly/Loxo | Consultant | |
| ADC Therapeutics | Consultant | |
| Ono Pharmaceuticals | Consultant | |
| MorphoSys | Consultant/speaker | |
| Mehdi Hamadani, MD | ADC Therapeutics | Consultant/Speaker/Researcher |
| Spectrum Pharmaceuticals | Researcher | |
| Astellas Pharma | Researcher | |
| Omeros | Consultant | |
| CRISPR | Consultant/speaker | |
| BMS | Consultant | |
| Kite Pharmaceuticals | Consultant/speaker | |
| Abbvie | Consultant | |
| Genmab | Consultant | |
| Allovir | Consultant | |
| Caribou | Consultant | |
| AstraZeneca | Speaker | |
| BeiGene | Speaker | |
| Genentech | Speaker | |
| Myeloid Therapeutics | Speaker |
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.